Gemres 200 mg Injection
Marketer
Resonance Laboratories Pvt Ltd
Salt Composition
Gemcitabine (200 mg)
Overview Gemres 200 mg Injection
Oncaspar 200 mg Injection treats several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administration is solely by a healthcare professional via injection. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; improper usage or overdose can lead to severe complications. Benefits may take weeks or months to appear; discontinue only under medical guidance. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can lower blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels, along with cardiac, hepatic, and uric acid levels, are necessary. Inform your physician of any pre-existing heart, liver, or kidney conditions, and any concurrent medications, particularly anti-infectives, before starting treatment. Numerous drug interactions are possible; disclose all medications to your doctor. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is crucial throughout treatment to prevent conception.
Uses of Gemres 200 mg Injection
Lung cancer (non-small cell type), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Gemres 200 mg Injection:
This medication will be administered by your physician or their registered nurse; self-medication is strictly prohibited.
Common Side effects of Gemres 200 mg Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Gemres 200 mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Gemres 200 mg Injection works:
Gemres 200 mg Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential components. This action inhibits further cancer cell growth and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gemres 200 mg Injection and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Gemres 200 mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might deem the potential benefits outweigh the risks, but this is rare. Always seek medical advice.
Breast feedingUNSAFE
Administration of Gemres 200 mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The administration of Gemres 200 mg Injection can potentially reduce alertness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemres 200 mg Injection's application in individuals with impaired renal function. Physician consultation is essential. Pre-treatment kidney function assessment is recommended, along with ongoing monitoring post-therapy.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gemres 200 mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gemres 200 mg Injection :
NA
Facts to Know About Gemres 200 mg Injection
| Label | Value |
|---|---|
| Chemical Category | Cytosine Analog |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Metabolic inhibitors |
3,018 People bought this recently